Diana M Cardona Selected Research

Diana M Cardona Research Topics

Disease

30	Neoplasms (Cancer) 02/2024 - 09/2012
20	Sarcoma (Soft Tissue Sarcoma) 02/2024 - 10/2014
7	Graft vs Host Disease (Graft-Versus-Host Disease) 11/2022 - 05/2012
6	Neoplasm Metastasis (Metastasis) 01/2024 - 10/2014
3	Adenocarcinoma 03/2021 - 12/2009
3	Neurofibrosarcoma (MPNST) 01/2020 - 01/2017
2	Inflammation (Inflammations) 12/2023 - 04/2013
2	Reperfusion Injury 10/2023 - 04/2013
2	Fibrosis (Cirrhosis) 01/2023 - 01/2022
2	Infarction (Infarctions) 01/2022 - 02/2010
2	Residual Neoplasm 01/2016 - 01/2016
2	Carcinogenesis 01/2015 - 11/2014
1	Wounds and Injuries (Trauma) 12/2023
1	Second Primary Neoplasms (Neoplasms, Second) 12/2023
1	Intestinal Failure 10/2023
1	Carcinoma (Carcinomatosis) 09/2023
1	Microsatellite Instability 09/2023
1	Colorectal Neoplasms (Colorectal Cancer) 09/2023
1	Li-Fraumeni Syndrome 08/2023
1	Liver Diseases (Liver Disease) 01/2023
1	Sepsis (Septicemia) 11/2022
1	Hemorrhage 11/2022
1	Edema (Dropsy) 11/2022
1	Necrosis 01/2022
1	Rotator Cuff Injuries 11/2021
1	Idiopathic Thrombocytopenic Purpura (Thrombocytopenic Purpura, Autoimmune) 01/2021
1	Bronchiolitis Obliterans Syndrome 01/2021
1	Autoimmune Hepatitis 01/2021
1	Neoplasm Micrometastasis 02/2019
1	Hepatocellular Carcinoma (Hepatoma) 01/2019
1	Myxoid Liposarcoma 01/2019
1	Viremia 01/2018
1	Medulloblastoma 01/2018
1	Drug-Related Side Effects and Adverse Reactions 01/2018
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2017
1	Hodgkin Disease (Hodgkin's Disease) 01/2017
1	Melanoma (Melanoma, Malignant) 01/2017
1	Renal Cell Carcinoma (Grawitz Tumor) 01/2017
1	Margins of Excision 01/2016
1	Breast Neoplasms (Breast Cancer) 01/2016
1	Hypoxia (Hypoxemia) 06/2015

Drug/Important Bio-Agent (IBA)

4	Proteins (Proteins, Gene)FDA Link 02/2024 - 12/2010
4	Biomarkers (Surrogate Marker)IBA 09/2023 - 01/2012
3	Oncogene Proteins (Oncogene Protein)IBA 02/2024 - 03/2014
3	DNA (Deoxyribonucleic Acid)IBA 08/2023 - 06/2015
3	MicroRNAs (MicroRNA)IBA 12/2015 - 10/2014
2	Cre recombinaseIBA 02/2024 - 10/2017
2	RNA (Ribonucleic Acid)IBA 12/2023 - 11/2020
2	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2020 - 02/2019
2	Immunoglobulins (Immunoglobulin)IBA 01/2017 - 01/2012
2	ParaffinIBA 01/2017 - 01/2012
2	Peptide Hydrolases (Proteases)FDA Link 01/2016 - 01/2016
2	AntigensIBA 01/2012 - 12/2009
1	EpitopesIBA 02/2024
1	Indicators and Reagents (Reagents)IBA 01/2024
1	PrebioticsIBA 11/2022
1	Phenobarbital (Luminal)FDA Link 11/2022
1	Isoantigens (Alloantigen)IBA 01/2022
1	Deoxyglucose (2 Deoxy D glucose)IBA 01/2022
1	CollagenIBA 11/2021
1	B-Cell Activating FactorIBA 01/2021
1	Peptides (Polypeptides)IBA 01/2020
1	Cyclin-Dependent Kinase Inhibitor p16IBA 11/2019
1	F-Box-WD Repeat-Containing Protein 7IBA 11/2019
1	Sodium-Hydrogen Exchanger 3IBA 11/2019
1	olaratumabIBA 02/2019
1	brincidofovirIBA 01/2018
1	capmatinibIBA 01/2018
1	Mycophenolic Acid (Cellcept)FDA LinkGeneric 01/2018
1	trametinibIBA 01/2018
1	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 01/2018
1	Site-specific recombinaseIBA 10/2017
1	Formaldehyde (Formol)FDA Link 01/2017
1	Immune Checkpoint InhibitorsIBA 01/2017
1	NivolumabIBA 01/2017
1	LigandsIBA 01/2017
1	B7-H1 AntigenIBA 01/2017
1	SynaptophysinIBA 05/2016
1	EnzymesIBA 01/2016
1	Lysine (L-Lysine)FDA Link 01/2016
1	Fluorescent Dyes (Fluorescent Probes)IBA 01/2016
1	Acridine OrangeIBA 01/2016
1	Coloring Agents (Dyes)IBA 01/2016
1	AcriflavineIBA 11/2015
1	Hypoxia-Inducible Factor 1IBA 06/2015

Therapy/Procedure

10	Therapeutics 02/2024 - 09/2012
9	Radiotherapy 12/2023 - 03/2015
4	Transplantation 10/2023 - 08/2015
3	Hematopoietic Stem Cell Transplantation 10/2018 - 10/2012
2	Bone Marrow Transplantation (Transplantation, Bone Marrow) 01/2021 - 05/2012
2	Drug Therapy (Chemotherapy) 01/2020 - 01/2017
1	Neoadjuvant Therapy 01/2022
1	Liver Transplantation 01/2021
1	Chemoradiotherapy 10/2019
1	Aftercare (After-Treatment) 02/2019
1	Cell Transplantation 01/2018
1	Injections 01/2017
1	Intravenous Injections 01/2016
1	Laser Therapy (Surgery, Laser) 01/2016
1	Solid-State Lasers 01/2016